Extensive studies have demonstrated that AEBP2 (a zinc finger protein) ubiquitination and destruction mediated by SCF-β-TRCP ubiquitin ligase complex control cisplatin resistance in ovarian cancer[68]. The gene discussed is KITLG; the disease is ovarian carcinoma.